Skip to main content
. 2016 Feb 5;2016(2):CD008919. doi: 10.1002/14651858.CD008919.pub2

Egan 1992.

Methods Allocation: randomised.
 Blindess: double‐blind.
 Duration: Six weeks.
 Setting: mixed, USA.
 Design: cross‐over.
Participants Diagnosis: schizophrenia, other psychoses.
 N = 21.
 Sex: unclear, awaiting more information.
 Age: average 54 years.
Interventions 1. Vitamin E (1600 IU/day). N = 10
 2. Placebo. N = 11.
Outcomes Leaving the study early.
Psychiatric Symptom Assessment Scale.
Negative Symptom Rating Scale.
Notes